- ORCID iD
-
0000-0002-5019-1672
Show
Sort by
-
Ultra-deep sequencing and single cell multi-omics characterize measurable residual disease and identify therapy-survived clone in pediatric acute myeloid leukemia
(2024) -
- Conference Paper
- C3
- open access
Deciphering the non-coding landscape of pediatric acute myeloid leukemia
-
- Journal Article
- A1
- open access
TARP as antigen in cancer immunotherapy
-
Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach
-
- Journal Article
- A2
- open access
Leukaemic stem cells in AML : where are we now? An update on recent findings and detection
-
- PhD Thesis
- open access
Exploring the molecular and phenotypical heterogeneity between patients with pediatric acute myeloid leukemia
(2020) -
- Journal Article
- A1
- open access
Clinical significance of TARP expression in pediatric acute myeloid leukemia
-
- Journal Article
- A1
- open access
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
-
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia : proof of concept study
-
Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach